Rare variants in the neurotrophin signaling pathway implicated in schizophrenia risk

Schizophrenia Research

Volumn 168, Issue 1-2, 2015, Pages 421-428

  Kranz, Thorsten M ^a   Goetz, Ray R ^b,c   Walsh Messinger, Julie ^d,e   Goetz, Deborah ^f   Antonius, Daniel ^f,g   Dolgalev, Igor ^h   Heguy, Adriana ^h   Seandel, Marco ⁱ   Malaspina, Dolores ^f   Chao, Moses V ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Department of Psychiatry ^*  (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f NEW YORK UNIVERSITY   (United States)

^g UNIVERSITY AT BUFFALO   (United States)

^h NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

ARMS; De novo; Exome sequencing; Kidins220; Neurotrophin; Rare variant; Schizophrenia; Sporadic

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN 4; NEUROTROPHIN RECEPTOR; NEUROTROPHIN RECEPTOR P75; PROTEIN TYROSINE KINASE A;

ADULT; ARMS GENE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXOME; FEMALE; G7R GENE; GENE; GENE IDENTIFICATION; GENE LOCATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; INTELLIGENCE QUOTIENT; INTRACELLULAR SIGNALING; KIDINS220 GENE; LIGAND BINDING; MALE; MIDDLE AGED; MISSENSE MUTATION; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; NEUROPATHOLOGY; NEUROTROPHIN GENE; NGFR GENE; NT 3 GENE; NT 4 GENE; NTRK1 GENE; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; RECEPTOR BINDING; RISK ASSESSMENT; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SYNAPTIC TRANSMISSION; TRIO GENE; TRKB GENE; YOUNG ADULT; ADOLESCENT; ANALYSIS OF VARIANCE; COMPLICATION; DEPRESSION; GENETICS; INTELLIGENCE; METABOLISM; MOLECULAR MODEL; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; DEPRESSION; FEMALE; HUMANS; INTELLIGENCE; MALE; MIDDLE AGED; MODELS, MOLECULAR; NERVE GROWTH FACTORS; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84942370996     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.07.002     Document Type: Article

References (67)

1. Arevalo J.C., Yano H., Teng K.K., Chao M.V. A unique pathway for sustained neurotrophin signaling through an ankyrin-rich membrane-spanning protein. EMBO J. 2004, 23(12):2358-2368.
2. Arevalo J.C., Wu S.H., Takahashi T., Zhang H., Yu T., Yano H., Milner T.A., Tessarollo L., Ninan I., Arancio O., Chao M.V. The ARMS/Kidins220 scaffold protein modulates synaptic transmission. Mol. Cell. Neurosci. 2010, 45(2):92-100.
3. Arnedo J., Svrakic D.M., Del Val C., Romero-Zaliz R., Hernandez-Cuervo H., Genetics Molecular, of Schizophrenia Consortium, Fanous, A.H., Pato, M.T., Pato, C.N., de Erausquin, G.A., Cloninger, C.R., Zwir, I. Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. Am. J. Psychiatry 2015, 172(2):139-153.
4. Arons M.H., Thynne C.J., Grabrucker A.M., Li D., Schoen M., Cheyne J.E., Boeckers T.M., Montgomery J.M., Garner C.C. Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling. J. Neurosci. 2012, 32(43):14966-14978.
5. Bekinschtein P., Cammarota M., Medina J.H. BDNF and memory processing. Neuropharmacology 2014, 76(Part C(0)):677-683.
6. Bracale A., Cesca F., Neubrand V.E., Newsome T.P., Way M., Schiavo G. Kidins220/ARMS is transported by a kinesin-1-based mechanism likely to be involved in neuronal differentiation. Mol. Biol. Cell 2007, 18(1):142-152.
7. Bremner J.D., Vermetten E., Mazure C.M. Development and preliminary psychometric properties of an instrument for the measurement of childhood trauma: the Early Trauma Inventory. Depress. Anxiety 2000, 12(1):1-12.
8. Callaghan C.K., Kelly Á.M. Differential BDNF signaling in dentate gyrus and perirhinal cortex during consolidation of recognition memory in the rat. Hippocampus 2012, 22(11):2127-2135.
9. Caspi A., Moffitt T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat. Rev. Neurosci. 2006, 7(7):583-590.
10. Chao M.V. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 2003, 4(4):299-309.
11. Chen Y., Fu W.-Y., Ip J.P.K., Ye T., Fu A.K.Y., Chao M.V., Ip N.Y. Ankyrin repeat-rich membrane spanning protein (kidins220) is required for neurotrophin and ephrin receptor-dependent dendrite development. J. Neurosci. Off. J. Soc. Neurosci. 2012, 32(24):8263-8269.
12. Cross-Disorder Group of the Psychiatric Genomics C. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381(9875):1371-1379.
13. Deinhardt K., Kim T., Spellman D.S., Mains R.E., Eipper B.A., Neubert T.A., Chao M.V., Hempstead B.L. Neuronal growth cone retraction relies on proneurotrophin receptor signaling through Rac. Sci. Signal. 2011, 4(202):ra82.
14. Di Maria E., Giorgio E., Uliana V., Bonvicini C., Faravelli F., Cammarata S., Novello M.C., Galimberti D., Scarpini E., Zanetti O., Gennarelli M., Tabaton M. Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairment. J. Alzheimers Dis. 2012, 29(3):699-705.
15. Doherty J.L., O'Donovan M.C., Owen M.J. Recent genomic advances in schizophrenia. Clin. Genet. 2012, 81(2):103-109.
16. Dong S., Walker Michael F., Carriero Nicholas J., DiCola M., Willsey A.J., Ye Adam Y., Waqar Z., Gonzalez Luis E., Overton John D., Frahm S., Iii Keaney, John F., Teran Nicole A., Dea J., Mandell Jeffrey D., Hus Bal V., Sullivan Catherine A., DiLullo Nicholas M., Khalil Rehab O., Gockley J., Yuksel Z., Sertel Sinem M., Ercan-Sencicek A.G., Gupta Abha R., Mane Shrikant M., Sheldon M., Brooks Andrew I., Roeder K., Devlin B., State Matthew W., Wei L., Sanders Stephan J. De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. Cell Rep. 2014, 9(1):16-23.
17. Durany N., Michel T., Zochling R., Boissl K.W., Cruz-Sanchez F.F., Riederer P., Thome J. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr. Res. 2001, 52(1-2):79-86.
18. Fromer M., Pocklington A.J., Kavanagh D.H., Williams H.J., Dwyer S., Gormley P., Georgieva L., Rees E., Palta P., Ruderfer D.M., Carrera N., Humphreys I., Johnson J.S., Roussos P., Barker D.D., Banks E., Milanova V., Grant S.G., Hannon E., Rose S.A., Chambert K., Mahajan M., Scolnick E.M., Moran J.L., Kirov G., Palotie A., McCarroll S.A., Holmans P., Sklar P., Owen M.J., Purcell S.M., O'Donovan M.C. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014, 506(7487):179-184.
19. Fumagalli F., Molteni R., Racagni G., Riva M.A. Stress during development: impact on neuroplasticity and relevance to psychopathology. Prog. Neurobiol. 2007, 81(4):197-217.
20. Gauthier J., Spiegelman D., Piton A., Lafreniere R.G., Laurent S., St-Onge J., Lapointe L., Hamdan F.F., Cossette P., Mottron L., Fombonne E., Joober R., Marineau C., Drapeau P., Rouleau G.A. Novel de novo SHANK3 mutation in autistic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B(3):421-424.
21. Gauthier J., Champagne N., Lafreniere R.G., Xiong L., Spiegelman D., Brustein E., Lapointe M., Peng H., Cote M., Noreau A., Hamdan F.F., Addington A.M., Rapoport J.L., Delisi L.E., Krebs M.O., Joober R., Fathalli F., Mouaffak F., Haghighi A.P., Neri C., Dube M.P., Samuels M.E., Marineau C., Stone E.A., Awadalla P., Barker P.A., Carbonetto S., Drapeau P., Rouleau G.A., Team S.D. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(17):7863-7868.
22. Gehler S., Gallo G., Veien E., Letourneau P.C. p75 neurotrophin receptor signaling regulates growth cone filopodial dynamics through modulating RhoA activity. J. Neurosci. 2004, 24(18):4363-4372.
23. Glausier J.R., Lewis D.A. Dendritic spine pathology in schizophrenia. Neuroscience 2013, 251:90-107.
24. Goedert M., Fine A., Hunt S.P., Ullrich A. Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. Brain Res. 1986, 387(1):85-92.
25. Hefti F., Weiner W.J. Nerve growth factor and Alzheimer's disease. Ann. Neurol. 1986, 20(3):275-281.
26. Huang E.J., Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 2003, 72:609-642.
27. Iglesias T., Cabrera-Poch N., Mitchell M.P., Naven T.J., Rozengurt E., Schiavo G. Identification and cloning of Kidins220, a novel neuronal substrate of protein kinase D. J. Biol. Chem. 2000, 275(51):40048-40056.
28. Issa G., Wilson C., Terry A.V., Pillai A. An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. Neurobiol. Dis. 2010, 39(3):327-333.
29. Jiang X., Xu K., Hoberman J., Tian F., Marko A.J., Waheed J.F., Harris C.R., Marini A.M., Enoch M.A., Lipsky R.H. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 2005, 30(7):1353-1361.
30. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
31. Kim C.A., Bowie J.U. SAM domains: uniform structure, diversity of function. Trends Biochem. Sci. 2003, 28(12):625-628.
32. King B.H., Lord C. Is schizophrenia on the autism spectrum?. Brain Res. 2011, 1380:34-41.
33. Kong H., Boulter J., Weber J.L., Lai C., Chao M.V. An evolutionarily conserved transmembrane protein that is a novel downstream target of neurotrophin and ephrin receptors. J. Neurosci. Off. J. Soc. Neurosci. 2001, 21(1):176-185.
34. Konopaske G.T., Lange N., Coyle J.T., Benes F.M. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiatry 2014, 71(12):1323-1331.
35. Lin Z., Su Y., Zhang C., Xing M., Ding W., Liao L., Guan Y., Li Z., Cui D. The interaction of BDNF and NTRK2 gene increases the susceptibility of paranoid schizophrenia. PLoS One 2013, 8(9):e74264.
36. López-Menéndez C., Gascón S., Sobrado M., Vidaurre O.G., Higuero A.M., Rodríguez-Peña Á., Iglesias T., Díaz-Guerra M. Kidins220/ARMS downregulation by excitotoxic activation of NMDARs reveals its involvement in neuronal survival and death pathways. J. Cell Sci. 2009, 122(19):3554-3565.
37. Maisonpierre P.C., Le Beau M.M., Espinosa R., Ip N.Y., Belluscio L., de la Monte S.M., Squinto S., Furth M.E., Yancopoulos G.D. Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 1991, 10(3):558-568.
38. Mariga A., Zavadil J., Ginsberg S.D., Chao M.V. Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function. Dev. Neurobiol. 2015, 75(2):173-192.
39. Marler K.J., Becker-Barroso E., Martinez A., Llovera M., Wentzel C., Poopalasundaram S., Hindges R., Soriano E., Comella J., Drescher U. A TrkB/EphrinA interaction controls retinal axon branching and synaptogenesis. J. Neurosci. 2008, 28(48):12700-12712.
40. Maxwell M. Family Interview for Genetic Studies 1992, Clinical Neurogenetic Branch, Intramural Research Program, NIMH.
41. McGrath J.J., Féron F.P., Burne T.H.J., Mackay-Sim A., Eyles D.W. The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Ann. Med. 2003, 35(2):86-93.
42. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16(3):1215.
43. Minichiello L., Korte M., Wolfer D., Kuhn R., Unsicker K., Cestari V., Rossi-Arnaud C., Lipp H.P., Bonhoeffer T., Klein R. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 1999, 24(2):401-414.
44. Nakamura T., Sanokawa R., Sasaki Y., Ayusawa D., Oishi M., Mori N. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway. Oncogene 1996, 13(6):1111-1121.
45. Neubrand V.E., Thomas C., Schmidt S., Debant A., Schiavo G. Kidins220/ARMS regulates Rac1-dependent neurite outgrowth by direct interaction with the RhoGEF Trio. J. Cell Sci. 2010, 123(12):2111-2123.
46. Neubrand V.E., Cesca F., Benfenati F., Schiavo G. Kidins220/ARMS as a functional mediator of multiple receptor signalling pathways. J. Cell Sci. 2012, 125(8):1845-1854.
47. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., Reich T. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch. Gen. Psychiatry 1994, 51(11):849-859. (discussion 863-844).
48. Ortega J.A., Alcantara S. BDNF/MAPK/ERK-induced BMP7 expression in the developing cerebral cortex induces premature radial glia differentiation and impairs neuronal migration. Cereb. Cortex 2010, 20(9):2132-2144.
49. Park H., Poo M.M. Neurotrophin regulation of neural circuit development and function. Nat. Rev. Neurosci. 2013, 14(1):7-23.
50. Penzes P., Cahill M.E., Jones K.A., VanLeeuwen J.E., Woolfrey K.M. Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci. 2011, 14(3):285-293.
51. Purcell S.M., Moran J.L., Fromer M., Ruderfer D., Solovieff N., Roussos P., O'Dushlaine C., Chambert K., Bergen S.E., Kahler A., Duncan L., Stahl E., Genovese G., Fernandez E., Collins M.O., Komiyama N.H., Choudhary J.S., Magnusson P.K.E., Banks E., Shakir K., Garimella K., Fennell T., DePristo M., Grant S.G.N., Haggarty S.J., Gabriel S., Scolnick E.M., Lander E.S., Hultman C.M., Sullivan P.F., McCarroll S.A., Sklar P. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014, 506(7487):185-190.
52. Ray M.T., Shannon Weickert C., Webster M.J. Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders. Transcult. Psychiatry 2014, 4:e389.
53. Schultz J., Bork P., Ponting C.P., Hofmann K. SAM as a protein interaction domain involved in developmental regulation. Protein Sci. 1997, 6(1):249-253.
54. Schumacher J., Jamra R.A., Becker T., Ohlraun S., Klopp N., Binder E.B., Schulze T.G., Deschner M., Schmal C., Hofels S., Zobel A., Illig T., Propping P., Holsboer F., Rietschel M., Nothen M.M., Cichon S. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 2005, 58(4):307-314.
55. Shinawi M., Sahoo T., Maranda B., Skinner S.A., Skinner C., Chinault C., Zascavage R., Peters S.U., Patel A., Stevenson R.E., Beaudet A.L. 11p14.1 microdeletions associated with ADHD, autism, developmental delay, and obesity. Am. J. Med. Genet. A 2011, 155A(6):1272-1280.
56. Soliman F., Glatt C.E., Bath K.G., Levita L., Jones R.M., Pattwell S.S., Jing D., Tottenham N., Amso D., Somerville L.H., Voss H.U., Glover G., Ballon D.J., Liston C., Teslovich T., Van Kempen T., Lee F.S., Casey B.J. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 2010, 327(5967):863-866.
57. Sullivan P.F., Magnusson C., Reichenberg A., Boman M., Dalman C., Davidson M., Fruchter E., Hultman C.M., Lundberg M., Langstrom N., Weiser M., Svensson A.C., Lichtenstein P. Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch. Gen. Psychiatry 2012, 69(11):1099-1103.
58. Tsai S.J., Cheng C.Y., Yu Y.W., Chen T.J., Hong C.J. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 123B(1):19-22.
59. Verhagen M., van der Meij A., van Deurzen P.A., Janzing J.G., Arias-Vasquez A., Buitelaar J.K., Franke B. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol. Psychiatry 2010, 15(3):260-271.
60. Wang X., McCoy P.A., Rodriguiz R.M., Pan Y., Je H.S., Roberts A.C., Kim C.J., Berrios J., Colvin J.S., Bousquet-Moore D., Lorenzo I., Wu G., Weinberg R.J., Ehlers M.D., Philpot B.D., Beaudet A.L., Wetsel W.C., Jiang Y.-H. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum. Mol. Genet. 2011, 20(15):3093-3108.
61. Wechsler D. Wechsler Abbreviated Scale of Intelligence 1999.
62. Weickert C.S., Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., Kleinman J.E. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 2003, 8(6):592-610.
63. White L., Harvey P.D., Opler L., Lindenmayer J.P. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology 1997, 30(5):263-274.
64. Wu S.H., Arevalo J.C., Sarti F., Tessarollo L., Gan W.-B., Chao M.V. Ankyrin repeat-rich membrane spanning/Kidins220 protein regulates dendritic branching and spine stability in vivo. Dev. Neurobiol. 2009, 69(9):547-557.
65. Yeo G.S., Connie Hung C.C., Rochford J., Keogh J., Gray J., Sivaramakrishnan S., O'Rahilly S., Farooqi I.S. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat. Neurosci. 2004, 7(11):1187-1189.
66. Zampieri N., Chao M.V. Mechanisms of neurotrophin receptor signalling. Biochem. Soc. Trans. 2006, 34(Pt 4):607-611.
67. Zou Y.F., Wang Y., Liu P., Feng X.L., Wang B.Y., Zang T.H., Yu X., Wei J., Liu Z.C., Liu Y., Tao M., Li H.C., Li K.Q., Hu J., Li M., Zhang K.R., Ye D.Q., Xu X.P. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients. Neuropsychobiology 2010, 61(2):71-78.